Trans-Tasman Mutual Recognition (South Australia) Variation Regulations 2011 (SA)

South Australia

Trans-Tasman Mutual Recognition (South Australia) Variation Regulations 2011

under the Trans-Tasman Mutual Recognition (South Australia) Act 1999

Contents

Part 1—Preliminary

1            Short title

2            Commencement

3            Variation provisions

Part 2—Variation of Trans-Tasman Mutual Recognition (South Australia) Regulations 1999

4            Insertion of regulation 9

9            Temporary exemptions—synthetic cannabis products

Part 1—Preliminary

1—Short title

These regulations may be cited as the Trans-Tasman Mutual Recognition (South Australia) Variation Regulations 2011.

2—Commencement

These regulations come into operation on the day on which they are made.

3—Variation provisions

In these regulations, a provision under a heading referring to the variation of specified regulations varies the regulations so specified.

Part 2—Variation of Trans-Tasman Mutual Recognition (South Australia) Regulations 1999

4—Insertion of regulation 9

After regulation 8 insert:

9—Temporary exemptions—synthetic cannabis products

(1)For the purposes of section 5 of the Act and section 46 of the Commonwealth Act, synthetic cannabis products are declared to be exempt from the operation of the Commonwealth Act.

(2)For the purposes of section 5 of the Act and section 46 of the Commonwealth Act, Part 5 of the Controlled Substances Act 1984 is declared to be exempt from the operation of the Commonwealth Act.

(3)The exemptions from the Commonwealth Act under this regulation have effect for a period of 12 months following the commencement of this regulation.

(4)In this regulation—

synthetic cannabis products means the following substances and any preparations containing 1 or more of the following substances:

(a)1-butyl-3-(1-naphthoyl)indole (JWH-073);

(b)1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (RCS-8);

(c)5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);

(d)5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol);

(e)1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694);

(f)1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201);

(g)1-hexyl-3-(1-naphthoyl)indole (JWH-019);

(h)9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (HU-210);

(i)4-methoxyphenyl(1butyl-1H-indol-3-yl)-methanone (RCS-4 (C4));

(j)1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);

(k)1-pentyl-3-(1-naphthoyl)indole (JWH-018);

(l)1-pentyl-3-[1-(4-methoxynaphthoyl)indole (JWH‑081);

(m)1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH‑122);

(n)1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);

(o)1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH‑398);

(p)1-pentyl-3-[(4-methoxy)-benzoyl]indole (RCS‑4);

(q)Pravadoline (WIN 48098).

Note—

As required by section 10AA(2) of the Subordinate Legislation Act 1978, the Minister has certified that, in the Minister's opinion, it is necessary or appropriate that these regulations come into operation as set out in these regulations.

Made by the Governor

with the advice and consent of the Executive Council

on 23 June 2011

No 166 of 2011

AGO0215/11CS